Faculty Scholars

Janice Withycombe

Janice Withycombe, Ph.D.

Associate Professor
School of Nursing
College of Behavioral, Social and Health Sciences

Contact: 864-720-2224 or jswithy@clemson.edu 

Who is Dr. Withycombe?

Dr. Withycombe completed her Ph.D. in Nursing at the University of Arizona in Tucson in 2012. She moved from Emory University in Atlanta, Georgia to join the faculty at Clemson University in August 2019. Research areas include physical activity, patient reported outcomes and patient/family education. Current research involves the use of metabolomics to explore relationships between oxidative stress, physical activity and patient symptoms in children receiving treatment for cancer. Her research related to physical activity seeks to utilize interventions in both an in-patient and community (pediatric oncology camp) setting. She strongly supports capturing the voice of children during cancer therapy and as such, has worked on multiple studies related to instrument development and validation for pediatric Patient Reported Outcome (PRO) measures (specifically Pediatric PROMIS and Pediatric PRO-Common Terminology Criteria of Adverse Events). She currently serves as Chair of the Nursing Research committee within the Children’s Oncology Group which is the is the world’s largest organization devoted exclusively to cancer research in children and adolescents.

For more information, see her Department Profile.

How Dr. Withycombe’s research is transforming health care

Dr. Withycombe strongly believes that research must be moved into practice to impact improvements in clinical care. For this reason, she has led national evidence-based practice initiatives through the Children’s Oncology Group and has published recommendations for nursing practice related to the care of childhood cancer patients. Prior research findings have been incorporated into national clinical practice guidelines that have contributed to large-scale practice changes. Additionally, she has helped to develop pediatric patient reported outcome measures which are used within pediatric clinical trials to better understand the burden of cancer treatment from the child’s perspective. This has included research to develop and validate the Pediatric PRO-CTCAE (Patient Reported Outcome – Common Terminology Criteria for Adverse Events) instrument which is now being used in a variety of pediatric oncology trails at a national level. Collected Patient Reported Outcome data can assist with more accurate assessment of toxicities which may lead to better symptom management and improved outcomes for patients.

Health Research Expertise Keywords

Pediatric oncology, Physical activity, Metabolomics, Patient/family education, Patient reported outcomes, Pediatric oncology summer camps